D-Talosamin | 530-23-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: D-Talosamin
• 英文别名: 2-amino-D-2-deoxy-talose；D-Talosamine；(3S,4R,5R,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
• CAS: 530-23-4
• 化学式: C₆H₁₃NO₅
• 分子量: 179.173
• InChiKey: MSWZFWKMSRAUBD-SVZMEOIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  116
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES
  申请人：California Institute of Technology

  公开号：US20170049903A1

  公开（公告）日：2017-02-23

  The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. The invention also relates to a method of preparing a composition. The method combines a therapeutic agent, a polymer having host or guest functionality, and a complexing agent having guest or host functionality to form the therapeutic composition. The complexing agent forms an inclusion complex with the polymer. The invention also relates to a method of delivering a therapeutic agent. According to the method, a therapeutically effective amount of a therapeutic composition of the invention is administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. Also disclosed are compounds having the formula:

  该发明提供了一种含有聚合物和治疗剂的颗粒复合物的组合物。该组合物还包含一种络合剂。聚合物与络合剂在宿主-客体或客体-宿主相互作用中相互作用，形成包含复合物。该发明的治疗组合物可用于传递治疗剂并治疗各种疾病。颗粒复合物的聚合物和络合剂均可用于向治疗组合物引入功能。该发明还涉及一种制备组合物的方法。该方法将治疗剂、具有宿主或客体功能的聚合物以及具有客体或宿主功能的络合剂结合在一起，形成治疗组合物。络合剂与聚合物形成包含复合物。该发明还涉及一种传递治疗剂的方法。根据该方法，在确实需要治疗的已知需要治疗的哺乳动物（例如人或动物）体内给予该发明的治疗组合物的治疗有效量。还披露了具有以下结构的化合物：
• COMPOSITIONS CONTAINING INCLUSION COMPLEXES
  申请人：Calando Pharmaceuticals, Inc.

  公开号：US20150050233A1

  公开（公告）日：2015-02-19

  The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. The invention also relates to a method of preparing a composition. The method combines a therapeutic agent, a polymer having host or guest functionality, and a complexing agent having guest or host functionality to form the therapeutic composition. The complexing agent forms an inclusion complex with the polymer. The invention also relates to a method of delivering a therapeutic agent. According to the method, a therapeutically effective amount of a therapeutic composition of the invention is administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. Also disclosed are compounds having the formula:

  本发明提供了一种含有聚合物和治疗剂的颗粒复合物的组合物。该组合物还含有一种络合剂。聚合物与络合剂以主-客或客-主交互作用相互作用，形成包含复合物。本发明的治疗组合物可用于传递治疗剂并治疗各种疾病。颗粒复合物的聚合物和络合剂均可用于向治疗组合物引入功能。本发明还涉及一种制备组合物的方法。该方法将治疗剂、具有主或客功能的聚合物和具有客或主功能的络合剂结合起来形成治疗组合物。络合剂与聚合物形成包含复合物。本发明还涉及一种传递治疗剂的方法。根据该方法，将本发明的治疗组合物的治疗有效量用于需要治疗的哺乳动物（例如人或动物）。还公开了具有以下公式的化合物：
• PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL
  申请人：Inbiose N.V.

  公开号：EP3954769A1

  公开（公告）日：2022-02-16

  The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of fermentation of metabolically engineered cells. The present invention provides a method for the production of a mixture of at least two different oligosaccharides by a cell as well as the purification of at least one of said oligosaccharides from the cultivation. In addition, the present invention provides a method for the production of a mixture of at least two different oligosaccharides by a metabolically engineered cell as well as the purification of at least one of said oligosaccharides from the cultivation.

  本发明属于合成生物学和代谢工程技术领域。更具体地说，本发明属于代谢工程细胞发酵技术领域。本发明提供了一种细胞生产至少两种不同低聚糖混合物的方法，以及从培养物中纯化至少一种所述低聚糖的方法。此外，本发明还提供了一种通过代谢工程细胞生产至少两种不同低聚糖混合物以及从培养物中纯化至少一种所述低聚糖的方法。
• PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL
  申请人：Inbiose N.V.

  公开号：EP3954778A1

  公开（公告）日：2022-02-16

  The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of fermentation of metabolically engineered cells. The present invention describes a metabolically engineered cell for production of a mixture of at least three different neutral non-fucosylated oligosaccharides. Furthermore, the present invention provides a method for the production of a mixture of at least three different neutral non-fucosylated oligosaccharides by a cell as well as the purification of at least one of said oligosaccharides from the cultivation.

  本发明属于合成生物学和代谢工程技术领域。更具体地说，本发明属于代谢工程细胞发酵技术领域。本发明描述了一种用于生产至少三种不同中性非岩藻糖基化低聚糖混合物的代谢工程细胞。此外，本发明还提供了一种细胞生产至少三种不同的中性非琥珀酰化低聚糖混合物的方法，以及从培养物中纯化至少一种所述低聚糖的方法。
• GLYCOMINIMIZED BACTERIAL HOST CELLS
  申请人：Inbiose N.V.

  公开号：EP4103685A1

  公开（公告）日：2022-12-21